![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 33, 25292-25298, August 18, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
§,
§,
§,
§,
§,
§
From the In this study, regulation of transcription factor
NF-E2 was examined in differentiating erythroid and myeloid
cells, and the impact of raising NF-E2 concentrations within these cell
types was assessed. NF-E2 was expressed in the J2E erythroid cell line, but the levels increased only marginally during erythropoietin-induced differentiation. In contrast, rare myeloid variants of J2E cells did
not express NF-E2. Although NF-E2 was present in M1 monoblastoid cells,
it was undetectable as these cells matured into macrophages. Compared
with erythroid cells, transcription of the NF-E2 gene was reduced, and
the half-life of the mRNA was significantly shorter in monocytoid
cells. Ectopic expression of NF-E2 had a profound impact upon the J2E
cells; morphologically mature erythroid cells spontaneously emerged in
culture, but the cells failed to synthesize hemoglobin, even in the
presence of erythropoietin. Although proliferation and viability
increased in the NF-E2-transfected J2E cells, their responsiveness to
erythropoietin was severely diminished. Strikingly, increasing the
expression of NF-E2 in M1 cells produced sublines that contained
erythroid or immature megakaryocytic cells. Finally, overexpression of
NF-E2 in primary hemopoietic progenitors from fetal liver increased
erythroid colony formation in the absence of erythropoietin. These data
demonstrate that elevated NF-E2 (i) had a dominant effect on the
phenotype and maturation of J2E erythroid cells, (ii) was able to
reprogram the M1 monocytoid line, and (iii) promoted the development of
erythroid colonies by normal progenitors.
Laboratory for Cancer Medicine, Western
Australian Institute for Medical Research, Royal Perth Hospital, Perth
WA 6000, Australia, the § Department of Biochemistry,
University of Western Australia, Nedlands 6907, Australia, and the
¶ Howard Hughes Medical Institute, Children's Hospital, and
Harvard Medical School, Boston, Massachusetts 02115
To whom correspondence should be addressed: Western Australian
Inst. for Medical Research, Level 6, MRF Bldg., Rear 50 Murray St.,
Perth WA 6000, Australia. Tel.: 61-8-92240334; Fax: 61-8-92240322; E-mail: pklinken@cyllene.uwa.edu.au.
This article has been cited by other articles:
![]() |
P. J. Campbell and A. R. Green The Myeloproliferative Disorders N. Engl. J. Med., December 7, 2006; 355(23): 2452 - 2466. [Full Text] [PDF] |
||||
![]() |
J.-P. Lalonde, R. Lim, E. Ingley, P. A. Tilbrook, M. J. Thompson, R. McCulloch, J. G Beaumont, C. Wicking, H. J. Eyre, G. R. Sutherland, et al. HLS5, a Novel RBCC (Ring Finger, B Box, Coiled-coil) Family Member Isolated from a Hemopoietic Lineage Switch, Is a Candidate Tumor Suppressor J. Biol. Chem., February 27, 2004; 279(9): 8181 - 8189. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-J. Liu, S.-C. Hou, and C.-K. J. Shen Erythroid Gene Suppression by NF-{kappa}B J. Biol. Chem., May 23, 2003; 278(21): 19534 - 19540. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Pratt, A. Drejer, H. Foott, B. Barut, A. Brownlie, J. Postlethwait, Y. Kato, M. Yamamoto, and L. I. Zon Isolation and characterization of zebrafish NFE2 Physiol Genomics, October 29, 2002; 11(2): 91 - 98. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |